CUA Educational Content

How have the recent clinical trials in Prostate Cancer informed my practice choices?

Session #2 of the Prostate Cancer and Cardiovascular Disease program series
In partnership with IC-OS and EAU



  • The shifting landscape of hormonal therapy for advanced prostate cancer, with earlier implementation of androgen pathway
  • How does real life treatment of prostate cancer differ from patients defined in clinical trials?
  • How does optimal CVD management influence overall outcome?
  • Collaboration across specialties?
  • How to monitor/minimize CV toxicity





This program has received financial support from Ferring in the form of an educational grant